Melatonin enhances pro-inflammatory cytokine levels and protects against Chagas disease

Journal of Pineal Research

Volumn 45, Issue 1, 2008, Pages 79-85

  Santello, Fabricia Helena ^a   Frare, Eduardo Osório ^a   Caetano, Leony Cristina ^a   AlonsoToldo, Míriam Paula ^a   Do Prado Jr , José Clóvis ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

interferon; Cytokines; Immune response; Macrophage; Melatonin; Trypanosoma cruzi

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MELATONIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HORMONE ACTION; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MALE; NONHUMAN; PARASITEMIA; PERITONEUM MACROPHAGE; RAT; TH1 CELL; TRYPANOSOMA CRUZI; UPREGULATION;

ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; CHAGAS DISEASE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON TYPE II; MALE; MELATONIN; MICE; MICE, INBRED C57BL; RATS; RATS, WISTAR; TRYPANOSOMA CRUZI;

EID: 47249088637     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00558.x     Document Type: Article

References (68)

1. Morel CM, Lazdins J. Chagas' disease. Nat Rev Microbiol 2003 1 : 14 15.
2. Nagib PR, Dutra WO, Chiari E et al. Trypanosoma cruzi: populations bearing opposite virulence induce differential expansion of circulating CD3+CD4-CD8- T cells and cytokine serum levels in young and adult rats. Exp Parasitol 2007 116 : 366 374.
3. Gazzinelli RT, Oswald IP, Hienry S et al. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-α. Eur J Immunol 1992 22 : 2501 2506.
4. Muñoz-Fernandez MA, Fernandez MA, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism. Immunol Lett 1992 33 : 35 40.
5. Vespa GN, Cunha FQ, Silva JS. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994 62 : 5177 5182.
6. Silva JS, Vespa GNR, Cardoso MAG et al. Tumor necrosis factor mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected interferon-activated macrophages. Infect Immun 1995 63 : 4862 4867.
7. Petray P, Castanos Velez E, Grinstein S et al. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol Lett 1995 47 : 121 126.
8. Saeftel M, Fleischer B, Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 2001 69 : 2252 2259.
9. Holscher C, Kohler G, Muller U et al. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in interferon receptor or inducible nitric oxide synthase. Infect Immun 1998 66 : 1208 1215.
10. Michailowsky V, Silva NM, Rocha CD et al. Pivotal role of interleukin-12 and interferon axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol 2001 159 : 1723 1733.
11. Dokoro CE, Vallochi AL, Rios LS et al. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi. J Autoimmun 2004 23 : 103 115.
12. Ropert C, Gazzinelli RT. Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa. Curr Opin Microbiol 2000 3 : 395 403.
13. Higuchi ML, Benvenutti LA, Reis MM et al. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 2003 15 : 96 107.
14. Gomes JAS, Bahia-Oliveira LMG, Rocha MOC et al. Evidence that development of severe cardiomyopathy in human Chagas disease is due to a Th1 specific response. Infect Immun 2003 71 : 1185 1193.
15. Talvani A, Rocha MOC, Barcelos LS et al. Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 2004 38 : 943 950.
16. Hunter CA, Slifer T, Araujo F. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect Immun 1996 64 : 2381 2386.
17. Aliberti JC, Cardoso MA, Martins GA et al. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 1996 64 : 1961 1967.
18. Reed SG. In vivo administration of recombinant IFN-g induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immunol 1988 140 : 4342 4347.
19. Costa VM, Torres KC, Mendonca RZ et al. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J Immunol 2006 177 : 3193 3200.
20. Blalock JE. The syntax of immune-neuroendocrine communication. Immunol Today 1994 15 : 504 511.
21. Black PH. Psychoneuroimmunology: brain and immunity. Sci Am 1995 2 : 16 25.
22. Chesnokova V, Melmed S. Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002 143 : 1571 1574.
23. Carrillo-Vico A, Guerrero JM, Lardone PJ et al. A review of the multiple actions of melatonin on the immune system. Endocrine 2005 27 : 189 200.
24. Garcia-Maurino S, Gonzalez-Haba MG, Calvo JR et al. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J Immunol 1997 159 : 574 581.
25. Morrey KM, Mclachlan JA, Serkin CD et al. Activation of human monocytes by the pineal hormone melatonin. J Immunol 1994 153 : 2671 2680.
26. Barjavel MJ, Mamdouh Z, Raghbate N et al. Differential expression of the melatonin receptor in human monocytes. J Immunol 1998 160 : 1191 1197.
27. Lissoni P, Rovelli F, Brivio F et al. Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light/dark rhythm of the pineal hormone melatonin in healthy humans. Nat Immunity 1998 16 : 1 5.
28. Santello FH, Frare EO, Dos Santos CD et al. Melatonin treatment reduces the severity of experimental Trypanosoma cruzi infection. J Pineal Res 2007 42 : 359 363.
29. Avunduk AM, Avunduk MC, Baltaci AK et al. Effect of zinc and melatonin supplementation on cellular immunity in rats with toxoplasmosis. Biol Trace Elem Res 2003 96 : 237 245.
30. Valero N, Marinaespina L, Bonilla E, Mosquera J. Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus. J Pineal Res 2007 42 : 107 112.
31. Silva LHP, Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin Biol 1953 20 : 191 201.
32. Brener Z. Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 1962 4 : 389 396.
33. Griess P. Bemerkungen zu der Abhandlung der H.H.Weselsky und Benedikt Uber einige Azoverbindungen'. Chem Ber 1879 12 : 426.
34. Dos Reis GA, Freire-De-Lima CG, Nunes MP et al. The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol 2005 21 : 237 243.
35. Martin DL, Weatherly DB, Laucella SA et al. CD8+ T-cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog 2006 2 : e77.
36. Ouaissi A, Ouaissi M. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases. Arch Immunol Ther Exp (Warsz) 2005 53 : 102 114.
37. Martin DL, Tarleton RL. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol 2005 174 : 1594 1601.
38. Binkley SA. Circadian rhythms of pineal function in rats. Endocr Rev 1983 4 : 255 270.
39. Lieberman HR, Waldhauser F, Garfield G et al. Effects of melatonin on human mood and performance. Brain Res 1984 323 : 201 207.
40. Reiter RJ. The mammalian pineal gland: structure and function. Am J Ana 1981 162 : 287 313.
41. Krause DN, Dubocovich ML. Regulatory sites in the melatonin system of mammals. Trends Neurosci 1990 13 : 464 470.
42. Amstrong SM. Entrainment of vertebrate circadian rhythms by melatonin. Adv Pineal Res 1991 5 : 259 266.
43. Garcia-Perganeda A, Guerrero JM, Raffi-El-Idrissi M et al. Characterization of membrane melatonin receptor in mouse peritoneal macrophages: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein. J Neuroimmunol 1999 95 : 85 94.
44. Carrillo-Vico A., Garcia-Perganeda A., Naji L et al. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell Mol Life Sci 2003 60 : 2272 2278.
45. Rager-Zisman B, Allison AC. The role of antibodies and host cells in the resistance of mice against infection by Coxsakie B3 virus. J Gen Virol 1973 19 : 329 338.
46. Thong HY, Vincent MM, Hensen SA et al. Depressed specific cell mediated immunity to herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immun 1975 12 : 76 80.
47. Maestroni GJM, Conti A, Pierpaoli W. Pineal melatonin, its fundamental immuno-regulatory role in aging and cancer. Ann N Y Acad Sci 1988 521 : 140 148.
48. Ben-Nathan D, Maestroni GJM, Lustig S et al. Protective effects of melatonin in mice infected with encephalitis viruses. Arch Virol 1995 140 : 223 230.
49. Zhang Z, Araghi-Niknam M, Liang B et al. Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection. Immunology 1999 96 : 291 297.
50. Crespo E, Macias M, Pozo D et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999 13 : 1537 1546.
51. Mei Q, Yu JP, Xu JM et al. Melatonin reduces colon immunological injury in rats by regulating activity of macrophages. Acta Pharmacol Sin 2002 23 : 882 886.
52. Zhanga S, Lib W, Gaob Q et al. Effect of melatonin on the generation of nitric oxide in murine macrophages. Eur J Pharmacol 2004 501 : 25 30.
53. O'garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998 8 : 275 283.
54. Murphy KM, Ouyang W, Farrar JD et al. Signaling and transcription in T helper development. Annu Rev Immunol 2000 18 : 451 494.
55. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003 3 : 133 146.
56. O'garra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000 10 : 542 550.
57. Ansel KM, Lee DU, Rao A. An epigenetic view of helper T cell differentiation. Nat Immunol 2003 4 : 616 623.
58. Reiter RJ, Melchiorri D, Sewerynek E et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995 18 : 1 11.
59. Shida CS, Castrucci AMI, Freund MT. High solubility of melatonin in aqueous medium. J Pineal Res 1994 16 : 198 201.
60. Maldonado MD, Murillo-Cabezas F, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007 42 : 1 11.
61. Rodríguez MI, Escames G, López LC et al. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence- accelerated mice. J Pineal Res 2007 42 : 272 279.
62. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
63. León J, Escames G, Rodríguez MI, López LC et al. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5- methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006 98 : 2023 2033.
64. Gibbs FP, Vriend J. The half-life of melatonin elimination from rat plasma. Endocrinology 1981 109 : 1796 1798.
65. El-Sokkary GH, Omar HM, Hassanein AF et al. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Radic Biol Med 2002 32 : 319 332.
66. Beraldo FH, Mikoshiba K, Garcia CR. Human malarial parasite, Plasmodium falciparum, displays capacitative calcium entry: 2-aminoethyl diphenylborinate blocks the signal transduction pathway of melatonin action on the P. falciparum cell cycle. J Pineal Res 2007 43 : 360 364.
67. Guha M, Maity P, Choubey V, Mitra K et al. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J Pineal Res 2007 43 : 372 381.
68. Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991 5 : 171 177.